Product logins

Find logins to all Clarivate products below.


: Analyst

Here you will find relevant articles and insight into all Clarivate related products and news.

Blog June 17, 2019
Breast Cancer: A Model Indication for Personalized Medicine
Analyst ASCO Breast Cancer
Blog August 22, 2018
It’s the end of the Medicare Shared Savings Program as we know it
ACO Analyst CMS
Blog June 25, 2018
Under ISP, How Will your Plan Assess an Oncology Drug’s Value for an Indication?
Analyst Indication-specific pricing Market Access
Blog May 9, 2018
Medicare Advantage leader eyes 50 percent penetration — but when?
Aetna Analyst Brandon Gee : Senior Analyst
Blog October 11, 2017
Opioid Epidemic Spawns Flurry of PBM Programs to Address Abuse
Amy Duval Analyst Business Insights Analyst
Blog June 29, 2017
Direct-to-consumer: New avenue for PBMs could provide political shelter
Affordable Care Act Amy Duval Analyst
Blog March 30, 2017
ACC.17: a roller coaster of results
alirocumab American College of Cardiology Amy Duval
Blog August 9, 2016
Opdivo falls short in the first-line CheckMate-026 NSCLC trial – what will the repercussions be on its commercial prospects?
Amy Duval Analyst Business Insights Analyst

Analyst

Blog June 17, 2019
Breast Cancer: A Model Indication for Personalized Medicine
Blog August 22, 2018
It’s the end of the Medicare Shared Savings Program as we know it
Blog June 25, 2018
Under ISP, How Will your Plan Assess an Oncology Drug’s Value for an Indication?
Blog May 9, 2018
Medicare Advantage leader eyes 50 percent penetration — but when?
Blog October 11, 2017
Opioid Epidemic Spawns Flurry of PBM Programs to Address Abuse
Blog June 29, 2017
Direct-to-consumer: New avenue for PBMs could provide political shelter
Blog March 30, 2017
ACC.17: a roller coaster of results
Blog August 9, 2016
Opdivo falls short in the first-line CheckMate-026 NSCLC trial – what will the repercussions be on its commercial prospects?